Subsea7 awarded a contract for the Belinda field in the UK North Sea
May 25, 2024 08:01 ET
|
Subsea 7 (Uk Service Co) Ltd
Luxembourg – 25 May 2024 - Subsea7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award of a sizeable1 contract by Serica Energy, for the Belinda field development south-east of the Triton...
Marine Moguls ERC-404 Launch with $2.9 Million in Prizes for Token Holders!
May 25, 2024 08:00 ET
|
Marine Moguls by MetFi
Seoul, South Korea, May 25, 2024 (GLOBE NEWSWIRE) -- Marine Moguls has officially launched on the revolutionary ERC-404 protocol, ushering in a new era of digital asset innovation. ...
ValueZone CEO Highlights Strategy Behind Its Top-Rated Trading Platform
May 25, 2024 08:00 ET
|
ValueZone
London, England, May 25, 2024 (GLOBE NEWSWIRE) -- During a recent industry conference, Adam Carl Waldman, CEO of ValueZone, detailed the strategies that have positioned ValueZone as one of the...
Tournée média internationale à Maoming, ville pétrolière de la côte chinoise et plus grande zone de production de litchis au monde
May 25, 2024 07:39 ET
|
Information Office of Maoming Municipal Government
MAOMING, Chine, 25 mai 2024 (GLOBE NEWSWIRE) -- Du 21 au 23 mai, la délégation média « Chinese Culture Tour » (ou Circuit culturel chinois), composée de journalistes et de photographes de renommée...
Crydit Unveils Revolutionary Unlimited Crypto Card Redefining Crypto Payments
May 25, 2024 07:00 ET
|
Crydit
London, England, May 25, 2024 (GLOBE NEWSWIRE) -- Crydit, with the vision of “Pay Everything,” announces the official launch of the first Unlimited Crypto Card in the industry. Crydit is poised to...
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio
May 25, 2024 06:15 ET
|
Novartis Pharma AG
In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo
May 25, 2024 06:00 ET
|
Novartis Pharma AG
Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical...
WOW (NYSE) ALERT: WideOpenWest’s $4.80 Per Share Offer from DigitalBridge is Under Investigation; Contact BFA Law to Discuss Your Rights
May 25, 2024 05:24 ET
|
Bleichmar Fonti & Auld
NEW YORK, May 25, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the (NYSE: WOW) WideOpenWest merger with DigitalBridge and Crestview. If you invested in...
SQSP (NYSE) ALERT: Squarespace’s $44 Per Share Buyout Offer From Permira is Under Investigation; Contact BFA Law to Discuss Your Rights
May 25, 2024 05:23 ET
|
Bleichmar Fonti & Auld
NEW YORK, May 25, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the (NYSE: SQSP) Squarespace buyout from Permira. If you invested in Squarespace you are...
SPT (NASDAQ) ALERT: Investors in Sprout Social that Lost Money when Stock Tumbled 40% Are Encouraged to Contact BFA Law by July Deadline in Class Action Lawsuit
May 25, 2024 05:20 ET
|
Bleichmar Fonti & Auld
NEW YORK, May 25, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 12, 2024 deadline in the (Nasdaq: SPT) Sprout Social Securities Class Action...
- May 24, 2024 20:18 ET Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against Biogen Inc. (BIIB)
- May 24, 2024 20:06 ET Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against Direct Digital Holdings, Inc. (DRCT)